Auro Laboratories Posts Strong FY26 Growth

₹30.74 crore Revenue, ₹3.53 crore Net Profit.

Reader Takeaway: Strong profit and revenue growth driven by operational efficiency, balanced by a new gratuity provision.

What just happened

Auro Laboratories Limited has announced its financial results for the year ended March 31, 2026. The company reported a significant jump in revenue and net profit.

Why this matters

This strong financial performance indicates improved operational efficiency and market traction for Auro Laboratories. The substantial growth in both revenue and profit is a positive sign for shareholders.

The backstory

For the financial year 2026, Auro Laboratories' revenue from operations increased by approximately 58.46% to ₹30.74 crore, compared to ₹19.40 crore in FY 2025. Net profit saw an even more impressive rise of 91.86%, reaching ₹3.53 crore from ₹1.84 crore in the previous year.

What changes now

The company has made key appointments for the new financial year. Mr. Nitesh Bohra has been appointed as the Chief Financial Officer (CFO) and Key Managerial Personnel, effective May 29, 2026. Additionally, auditors for the upcoming financial year have been appointed: M/s. B.L. Dasharda & Associates as Tax Auditor, Mr. Kuntal Pancholi as Internal Auditor, and M/s. Poddar & Co. re-appointed as Cost Auditor for FY 2026-27.

Risks to watch

Auro Laboratories recorded a provision of ₹0.31 crore for gratuity, as per new Labour Code requirements. The incremental impact of this provision on the reported results is ₹0.14 crore. While this is a one-time adjustment due to regulatory changes, it marginally impacts the profit.

Peer comparison

(Data not available in the filing. Grounded search is required for this section.)

Context metrics (time-bound)

• Revenue (FY 2026): ₹30.74 crore (₹3,073.98 lakh)
• Net Profit (FY 2026): ₹3.53 crore (₹353.29 lakh)
• Revenue Growth (YoY): +58.46%
• Net Profit Growth (YoY): +91.86%
• Basic EPS (FY 2026): ₹5.67
• Gratuity Provision: ₹0.31 crore

What to track next

Investors will be keen to see if Auro Laboratories can sustain this growth momentum in the next financial year, especially under the new CFO. Monitoring the impact of the gratuity provision and continued operational efficiency will be crucial.